Quick answers
- What is Lyrica?
- Lyrica is a brand name of Pregabalin, a prescription medicine. The FDA NDC Directory lists 10 Lyrica products in 9 strengths and forms.
- Who makes Lyrica?
- Upjohn holds the FDA application for Lyrica (NDA021446, approved December 30, 2004). 1 other company (repackagers or distributors) also list Lyrica products.
- Is there a generic or store brand of Lyrica?
- Yes. The FDA NDC Directory lists 521 other products with the same active ingredients, strength and form as a Lyrica product, 521 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Lyrica?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 8 Lyrica strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Lyrica been recalled?
- FDA enforcement reports list 2 recalls of Lyrica products; the newest started January 11, 2016. A recall usually concerns specific lots, not every product.
What Lyrica is
Each Lyrica product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Pregabalin · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| pregabalin 100 mg capsule (oral) | Lyrica | 74 products, 45 companies | DailyMed |
| pregabalin 150 mg capsule (oral) | Lyrica | 69 products, 41 companies | DailyMed |
| pregabalin 20 mg/mL solution (oral) | Lyrica | 3 products, 3 companies | DailyMed |
| pregabalin 200 mg capsule (oral) | Lyrica | 58 products, 40 companies | DailyMed |
| pregabalin 225 mg capsule (oral) | Lyrica | 50 products, 35 companies | DailyMed |
| pregabalin 25 mg capsule (oral) | Lyrica | 59 products, 40 companies | DailyMed |
| pregabalin 300 mg capsule (oral) | Lyrica | 56 products, 37 companies | DailyMed |
| pregabalin 50 mg capsule (oral) | Lyrica | 73 products, 45 companies | DailyMed |
| pregabalin 75 mg capsule (oral) | Lyrica | 79 products, 45 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Pregabalin →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| pregabalin 100 mg capsule | Brand: Lyrica | $9.69 per capsule Generic of the same strength and form: $0.0602 per capsule |
| pregabalin 150 mg capsule | Brand: Lyrica | $9.68 per capsule Generic of the same strength and form: $0.0585 per capsule |
| pregabalin 200 mg capsule | Brand: Lyrica | $9.68 per capsule Generic of the same strength and form: $0.0623 per capsule |
| pregabalin 225 mg capsule | Brand: Lyrica | $9.68 per capsule Generic of the same strength and form: $0.0683 per capsule |
| pregabalin 25 mg capsule | Brand: Lyrica | $9.68 per capsule Generic of the same strength and form: $0.0446 per capsule |
| pregabalin 300 mg capsule | Brand: Lyrica | $9.67 per capsule Generic of the same strength and form: $0.0690 per capsule |
| pregabalin 50 mg capsule | Brand: Lyrica | $9.68 per capsule Generic of the same strength and form: $0.0477 per capsule |
| pregabalin 75 mg capsule | Brand: Lyrica | $9.67 per capsule Generic of the same strength and form: $0.0556 per capsule |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Lyrica
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Lyrica products.
- Viatris Specialty LLC9 products
- Parke-Davis Div of Pfizer Inc1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
January 11, 2016 · Class II · Terminated · D-0648-2016
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
Lyrica (pregabalin) capsules, 50 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1013-68 — Pfizer Inc.
-
January 11, 2016 · Class II · Terminated · D-0649-2016
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68 — Pfizer Inc.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.